8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 6, 2026·SEC
Material company update
Mar 23, 2026·SEC
Guardian Pharmacy Services, Inc.(GRDN)Earnings, Financials & Key Ratios
GRDN•NYSE
54.4× P/E·Price updated Jun 19, 2026
AboutGuardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.Show more
- Revenue$1.45B+17.9%
- EBITDA$111M+357.8%
- Net Income$49M+156.4%
- EPS (Diluted)0.78+144.1%
- Gross Margin19.47%-2.1%
- EBITDA Margin7.68%+318.6%
- Operating Margin6.14%+219.8%
- Net Margin3.4%+147.8%
- ROE26.76%+132.2%
GRDN Key Insights
Guardian Pharmacy Services, Inc. (GRDN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 19.8%
- ✓Momentum leader: RS Rating 86 (top 14%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 14.5%
- ✓Trading near 52-week high
- ✓Efficient asset utilization: 3.5x turnover
✗Weaknesses
- ✗Thin 5Y average net margin of 0.9%
- ✗Expensive at 12.3x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GRDN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GRDN Price & Volume
Guardian Pharmacy Services, Inc. (GRDN) stock price & volume — 10-year historical chart
Loading chart...
GRDN Growth Metrics
Guardian Pharmacy Services, Inc. (GRDN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years14.5%
3 Years16.81%
TTM13.54%
Profit CAGR
10 Years-
5 Years19.8%
3 Years11.59%
TTM165.82%
EPS CAGR
10 Years-
5 Years18.77%
3 Years10.38%
TTM156.08%
Return on Capital
10 Years21.57%
5 Years18.54%
3 Years10.14%
Last Year41.49%
GRDN Recent Earnings
Guardian Pharmacy Services, Inc. (GRDN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (71%)●Beat Revenue 5/12 qtrs (71%)
Q2 2026Latest
May 6, 2026Metric
Actual
Est
EPS
$0.29+20.8%
$0.24
Rev
$337M+2.0%
$330M
Q2 2026
Mar 11, 2026Metric
Actual
Est
EPS
$0.37+37.0%
$0.27
Rev
$398M+1.9%
$390M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.25+4.2%
$0.24
Rev
$377M-3.2%
$390M
Q3 2025
Aug 11, 2025Metric
Actual
Est
EPS
$0.23+4.5%
$0.22
Rev
$344M+0.1%
$344M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.29vs $0.24+20.8% | $337Mvs $330M+2.0% |
| Q2 2026 | Mar 11, 2026 | $0.37vs $0.27+37.0% | $398Mvs $390M+1.9% |
| Q4 2025 | Nov 10, 2025 | $0.25vs $0.24+4.2% | $377Mvs $390M-3.2% |
| Q3 2025 | Aug 11, 2025 | $0.23vs $0.22+4.5% | $344Mvs $344M+0.1% |
Based on last 12 quarters of dataView full earnings history →
GRDN Peer Comparison
Guardian Pharmacy Services, Inc. (GRDN) competitors in Pharmacy and Long-Term Care Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 OMCL | 1.78B | 39.05 | 881.49 | 6.53% | 1.67% | 1.64% | 0.17 | |
 PINC | 2.34B | 28.26 | 128.45 | -10.86% | -2.42% | -1.59% | 0.18 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 CCRN | 425.82M | 13.17 | -4.49 | -21.56% | -9.84% | -27.1% | 0.01 | |
 MCK | 90.23B | 750.63 | 19.56 | 12.36% | 1.18% | |||
 CAH | 52.19B | 221.77 | 34.38 | -1.87% | 0.62% | |||
 VEEV | 24.9B | 153.30 | 28.18 | 16.34% | 28.37% | 13.36% | 0.01 | |
 ENSG | 8.98B | 153.65 | 26.31 | 18.72% | 6.89% | 16.61% | 1.86 |
Compare GRDN vs Peers
Guardian Pharmacy Services, Inc. (GRDN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GRDN Income Statement
Guardian Pharmacy Services, Inc. (GRDN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 600.37M | 698.29M | 735.96M | 792.07M | 908.91M | 1.05B | 1.23B | 1.45B | 1.46B |
Revenue Growth % | - | 16.31% | 5.39% | 7.62% | 14.75% | 15.1% | 17.42% | 17.93% | 13.54% |
Cost of Goods Sold | 477.33M | 554.83M | 588.96M | 630.81M | 723.04M | 837.88M | 984.04M | 1.17B | 1.16B |
COGS % of Revenue | 79.51% | 79.46% | 80.03% | 79.64% | 79.55% | 80.09% | 80.11% | 80.53% | - |
Gross Profit | 123.03M▲ 0% | 143.46M▲ 16.6% | 147M▲ 2.5% | 161.26M▲ 9.7% | 185.87M▲ 15.3% | 208.31M▲ 12.1% | 244.37M▲ 17.3% | 282.04M▲ 15.4% | 294M▲ 0% |
Gross Margin % | 20.49% | 20.54% | 19.97% | 20.36% | 20.45% | 19.91% | 19.89% | 19.47% | 20.19% |
Gross Profit Growth % | - | 16.6% | 2.47% | 9.7% | 15.25% | 12.08% | 17.31% | 15.42% | - |
Operating Expenses | 97.1M | 109.36M | 114.94M | 131.12M | 133.88M | 167.36M | 307.29M | 193.13M | 200.42M |
OpEx % of Revenue | 16.17% | 15.66% | 15.62% | 16.55% | 14.73% | 16% | 25.02% | 13.33% | - |
Selling, General & Admin | 87.84M | 97.56M | 102.54M | 131.12M | 133.88M | 167.36M | 307.29M | 220.02M | 227.31M |
SG&A % of Revenue | 14.63% | 13.97% | 13.93% | 16.55% | 14.73% | 16% | 25.02% | 15.19% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 9.26M | 11.8M | 12.4M | 0 | 0 | 0 | 0 | -26.89M | -1000K |
Operating Income | 25.93M▲ 0% | 34.1M▲ 31.5% | 32.06M▼ 6.0% | 30.15M▼ 6.0% | 51.99M▲ 72.4% | 40.95M▼ 21.2% | -62.92M▼ 253.7% | 88.91M▲ 241.3% | 93.58M▲ 0% |
Operating Margin % | 4.32% | 4.88% | 4.36% | 3.81% | 5.72% | 3.91% | -5.12% | 6.14% | 6.43% |
Operating Income Growth % | - | 31.5% | -5.97% | -5.97% | 72.44% | -21.24% | -253.67% | 241.31% | - |
EBITDA | 39.06M | 49.95M | 49.32M | 46.68M | 68.55M | 59.18M | -43.15M | 111.25M | 111.63M |
EBITDA Margin % | 6.51% | 7.15% | 6.7% | 5.89% | 7.54% | 5.66% | -3.51% | 7.68% | 7.67% |
EBITDA Growth % | - | 27.86% | -1.26% | -5.36% | 46.86% | -13.67% | -172.91% | 357.83% | 362.5% |
D&A (Non-Cash Add-back) | 13.13M | 15.85M | 17.26M | 16.53M | 16.56M | 18.23M | 19.77M | 22.34M | 18.05M |
EBIT | 25.17M | 33.62M | 31.82M | 29.96M | 51.59M | 40.58M | -63.2M | 88.91M | 83.82M |
Net Interest Income | -1.9M | -2.25M | -2.16M | -1.64M | -1.93M | -2.86M | -3.28M | -665K | -649K |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 1.9M | 2.25M | 2.16M | 1.64M | 1.93M | 2.86M | 3.28M | 665K | 649K |
Other Income/Expense | -2.66M | -2.73M | -2.4M | -1.82M | -2.33M | -3.23M | -3.56M | -15.49M | -14.97M |
Pretax Income | 23.27M▲ 0% | 31.37M▲ 34.8% | 29.66M▼ 5.5% | 28.33M▼ 4.5% | 49.66M▲ 75.3% | 37.72M▼ 24.0% | -66.48M▼ 276.2% | 73.42M▲ 210.4% | 78.61M▲ 0% |
Pretax Margin % | 3.88% | 4.49% | 4.03% | 3.58% | 5.46% | 3.61% | -5.41% | 5.07% | 5.4% |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 4.56M | 24.46M | 25.38M |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | -6.85% | 33.32% | 32.29% |
Net Income | 14.68M▲ 0% | 21.75M▲ 48.1% | 19.94M▼ 8.3% | 16.31M▼ 18.2% | 35.42M▲ 117.1% | 23.9M▼ 32.5% | -87.29M▼ 465.2% | 49.22M▲ 156.4% | 53.07M▲ 0% |
Net Margin % | 2.44% | 3.11% | 2.71% | 2.06% | 3.9% | 2.28% | -7.11% | 3.4% | 3.64% |
Net Income Growth % | - | 48.15% | -8.29% | -18.2% | 117.12% | -32.52% | -465.19% | 156.39% | 165.82% |
Net Income (Continuing) | 23.27M | 31.37M | 29.66M | 28.33M | 49.66M | 37.72M | -71.03M | 48.96M | 52.98M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 25.86M | 27.72M | 28.59M | 29.39M | 33.2M | 31.65M | 7.3M | 12.16M | 11.53M |
EPS (Diluted) | 0.24▲ 0% | 0.36▲ 50.0% | 0.33▼ 8.3% | 0.27▼ 18.2% | 0.58▲ 114.8% | 0.39▼ 32.8% | -1.77▼ 553.8% | 0.78▲ 144.1% | 0.83▲ 0% |
EPS Growth % | - | 50% | -8.33% | -18.18% | 114.81% | -32.76% | -553.85% | 144.07% | 156.08% |
EPS (Basic) | 0.24 | 0.36 | 0.33 | 0.27 | 0.58 | 0.39 | -1.77 | 0.79 | - |
Diluted Shares Outstanding | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 62.01M | 63.3M | 63.69M |
Basic Shares Outstanding | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 60.84M | 62.01M | 62.39M | 63.32M |
Dividend Payout Ratio | 156.1% | 114.56% | 54.23% | 106.39% | 86.97% | 160.75% | - | - | - |
GRDN Balance Sheet
Guardian Pharmacy Services, Inc. (GRDN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 81.23M | 90.08M | 93.82M | 111.87M | 120M | 129.6M | 151.99M | 221.63M | 235.18M |
Cash & Short-Term Investments | 2.25M | 275K | 6.45M | 15.01M | 607K | 752K | 4.66M | 65.62M | 64.89M |
Cash Only | 2.25M | 275K | 6.45M | 15.01M | 607K | 752K | 4.66M | 65.62M | 64.89M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 47.66M | 54.21M | 45.78M | 55.25M | 67.83M | 77.26M | 97.15M | 101.61M | 111.7M |
Days Sales Outstanding | 28.97 | 28.34 | 22.7 | 25.46 | 27.24 | 26.96 | 28.87 | 25.6 | 25.92 |
Inventory | 27.54M | 30.94M | 31.93M | 33.09M | 41.44M | 36.73M | 40.55M | 43.36M | 47.16M |
Days Inventory Outstanding | 21.06 | 20.35 | 19.79 | 19.15 | 20.92 | 16 | 15.04 | 13.57 | 14.33 |
Other Current Assets | 3.78M | 4.66M | 2.89M | 8.52M | 10.12M | 14.86M | 9.62M | 11.04M | 11.43M |
Total Non-Current Assets | 100.58M | 106.43M | 124.05M | 123.98M | 136.12M | 141.56M | 168.82M | 191.02M | 191.76M |
Property, Plant & Equipment | 27.98M | 35.41M | 51.98M | 51.72M | 65.19M | 73.18M | 78.96M | 90.17M | 90.89M |
Fixed Asset Turnover | 21.46x | 19.72x | 14.16x | 15.31x | 13.94x | 14.30x | 15.56x | 16.07x | 16.37x |
Goodwill | 47.82M | 46.33M | 52.45M | 54.63M | 56.05M | 56.05M | 69.3M | 79.74M | 79.74M |
Intangible Assets | 23.82M | 20.69M | 19.11M | 17.09M | 14.44M | 11.98M | 14.91M | 18.48M | 17.48M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 953K | 4.01M | 505K | 529K | 435K | 358K | 5.66M | 436K | 1.44M |
Total Assets | 181.81M▲ 0% | 196.51M▲ 8.1% | 217.87M▲ 10.9% | 235.85M▲ 8.3% | 256.11M▲ 8.6% | 271.17M▲ 5.9% | 320.81M▲ 18.3% | 412.66M▲ 28.6% | 426.94M▲ 0% |
Asset Turnover | 3.30x | 3.55x | 3.38x | 3.36x | 3.55x | 3.86x | 3.83x | 3.51x | 3.67x |
Asset Growth % | - | 8.09% | 10.87% | 8.25% | 8.59% | 5.88% | 18.31% | 28.63% | 85.31% |
Total Current Liabilities | 65.27M | 90.19M | 86.35M | 111.54M | 112M | 138.01M | 144.12M | 160.7M | 160.54M |
Accounts Payable | 47.53M | 54.93M | 53.41M | 64.62M | 78.1M | 85.6M | 102.42M | 116.21M | 108.55M |
Days Payables Outstanding | 36.34 | 36.14 | 33.1 | 37.39 | 39.43 | 37.29 | 37.99 | 36.36 | 35.45 |
Short-Term Debt | 2.64M | 17.04M | 3.63M | 3.71M | 7.96M | 12.98M | 0 | 0 | 7.22M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 7.68M | 9.94M | 0 | 20.42M | 3.62M | 12.33M | 16.65M | 37.35M | 31.98M |
Current Ratio | 1.24x | 1.00x | 1.09x | 1.00x | 1.07x | 0.94x | 1.05x | 1.38x | 1.46x |
Quick Ratio | 0.82x | 0.66x | 0.72x | 0.71x | 0.70x | 0.67x | 0.77x | 1.11x | 1.17x |
Cash Conversion Cycle | 13.69 | 12.55 | 9.39 | 7.21 | 8.73 | 5.66 | 5.92 | 2.81 | 4.81 |
Total Non-Current Liabilities | 48.53M | 49.28M | 64.44M | 70.99M | 68.18M | 73.29M | 26.71M | 34.03M | 33.97M |
Long-Term Debt | 36.37M | 33.66M | 30.74M | 26.99M | 22.97M | 18.99M | 0 | 0 | 0 |
Capital Lease Obligations | 2.35M | 3.59M | 15.54M | 16.12M | 23.67M | 27.04M | 26.71M | 29.99M | 119.69M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 9.81M | 12.03M | 18.16M | 27.88M | 21.54M | 27.26M | 0 | 4.04M | 4.31M |
Total Liabilities | 113.8M | 139.47M | 150.8M | 182.53M | 180.18M | 211.31M | 170.83M | 194.73M | 194.52M |
Total Debt | 43.71M | 57.12M | 58.84M | 55.04M | 62.98M | 69.15M | 37.33M | 37.14M | 36.88M |
Net Debt | 41.46M | 56.84M | 52.39M | 40.03M | 62.38M | 68.4M | 32.67M | -28.48M | -28.01M |
Debt / Equity | 0.64x | 2.06x | 0.88x | 1.03x | 0.83x | 1.16x | 0.25x | 0.17x | 0.16x |
Debt / EBITDA | 1.12x | 1.14x | 1.19x | 1.18x | 0.92x | 1.17x | - | 0.33x | 0.33x |
Net Debt / EBITDA | 1.06x | 1.14x | 1.06x | 0.86x | 0.91x | 1.16x | - | -0.26x | -0.25x |
Interest Coverage | 13.25x | 14.94x | 14.76x | 18.30x | 26.78x | 14.19x | -19.28x | 133.71x | 129.16x |
Total Equity | 68.01M▲ 0% | 27.72M▼ 59.2% | 67.07M▲ 142.0% | 53.32M▼ 20.5% | 75.93M▲ 42.4% | 59.86M▼ 21.2% | 149.98M▲ 150.5% | 217.92M▲ 45.3% | 232.42M▲ 0% |
Equity Growth % | - | -59.24% | 141.97% | -20.5% | 42.41% | -21.16% | 150.55% | 45.31% | 347.75% |
Book Value per Share | 1.12 | 0.46 | 1.10 | 0.88 | 1.25 | 0.98 | 2.42 | 3.44 | 3.65 |
Total Shareholders' Equity | 34.03M | 0 | 38.48M | 23.93M | 42.73M | 28.21M | 142.67M | 205.76M | 220.89M |
Common Stock | 34.03M | 29.95M | 39.15M | 24.11M | 42.73M | 28.21M | 63K | 63K | 63K |
Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 17.12M | 66.34M | 79.64M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -386K | -630K | -676K | -185K | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 25.86M | 27.72M | 28.59M | 29.39M | 33.2M | 31.65M | 7.3M | 12.16M | 11.53M |
GRDN Cash Flow Statement
Guardian Pharmacy Services, Inc. (GRDN) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 43.67M | 56.16M | 52.61M | 58.5M | 48.52M | 70.82M | 57.96M | 100.29M | 88.77M |
Operating CF Margin % | 7.27% | 8.04% | 7.15% | 7.39% | 5.34% | 6.77% | 4.72% | 6.92% | - |
Operating CF Growth % | - | 28.59% | -6.32% | 11.19% | -17.05% | 45.95% | -18.16% | 73.04% | 1359.58% |
Net Income | 23.27M | 31.37M | 29.66M | 28.33M | 49.66M | 37.72M | -71.03M | 49.22M | 53.07M |
Depreciation & Amortization | 13.13M | 15.85M | 17.26M | 16.53M | 16.56M | 18.23M | 19.77M | 22.34M | 23.04M |
Stock-Based Compensation | 5.98M | 1.93M | 3.21M | 13.03M | -3.38M | -6.09M | 131.49M | 13.85M | 9.88M |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.07M | 2.36M |
Other Non-Cash Items | 2.95M | 5.67M | 3.58M | 2.08M | 4.4M | 5.35M | 7.14M | 5.43M | 8.7M |
Working Capital Changes | -1.66M | 1.34M | -1.09M | -1.47M | -18.72M | 15.6M | -29.41M | 6.38M | -8.21M |
Change in Receivables | -8.79M | -11.13M | 3.58M | -7.71M | -16.79M | -14.3M | -25.48M | -8.55M | -18.68M |
Change in Inventory | 475K | -3.05M | 379K | -240K | -8.12M | 4.43M | -1.15M | -877K | -1.8M |
Change in Payables | 9.05M | 7.91M | -1.95M | 9.78M | 13.37M | 6.29M | 13.23M | 16.4M | 6.73M |
Cash from Investing | -20.75M | -16.59M | -12.18M | -13.15M | -17.9M | -13.44M | -30.41M | -32.26M | -31.35M |
Capital Expenditures | -10.01M | -14.54M | -8.34M | -9.28M | -16.77M | -14.56M | -16.37M | -19.58M | -18.76M |
CapEx % of Revenue | 1.67% | 2.08% | 1.13% | 1.17% | 1.85% | 1.39% | 1.33% | 1.35% | 1.29% |
Acquisitions | -10.68M | -2.07M | -4.38M | -4.4M | -2M | -985K | -14.71M | 0 | -4.15M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -57K | 16K | 545K | 535K | 874K | 2.1M | 671K | -12.68M | -8.44M |
Cash from Financing | -21.07M | -41.55M | -34.26M | -36.79M | -45.03M | -57.23M | -23.64M | -7.07M | -6.52M |
Debt Issued (Net) | 16.03M | 2.3M | -13.37M | -6.1M | -2.8M | -2.89M | -36.48M | -4.98M | -4.96M |
Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 64.61M | -1.59M | 0 |
Dividends Paid | -27.99M | -34.32M | -10.82M | -17.36M | -30.8M | -38.42M | -35.75M | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -55.18M | -29.04M | -30.28M |
Other Financing | -9.11M | -9.52M | -10.07M | -13.34M | -11.42M | -15.92M | -16.02M | -497K | -1.56M |
Net Change in Cash | 1.85M▲ 0% | -1.98M▼ 206.8% | 6.17M▲ 412.3% | 8.56M▲ 38.7% | -14.4M▼ 268.2% | 145K▲ 101.0% | 3.91M▲ 2595.2% | 60.96M▲ 1459.9% | 50.89M▲ 0% |
Free Cash Flow | 33.67M▲ 0% | 41.62M▲ 23.6% | 44.27M▲ 6.4% | 49.22M▲ 11.2% | 31.75M▼ 35.5% | 56.26M▲ 77.2% | 41.59M▼ 26.1% | 80.71M▲ 94.1% | 70.01M▲ 0% |
FCF Margin % | 5.61% | 5.96% | 6.02% | 6.21% | 3.49% | 5.38% | 3.39% | 5.57% | 4.81% |
FCF Growth % | - | 23.63% | 6.36% | 11.17% | -35.48% | 77.2% | -26.08% | 94.05% | 44.72% |
FCF per Share | 0.55 | 0.68 | 0.73 | 0.81 | 0.52 | 0.92 | 0.67 | 1.28 | 1.10 |
FCF Conversion (FCF/Net Income) | 2.98x | 2.58x | 2.64x | 3.59x | 1.37x | 2.96x | -0.66x | 2.04x | 1.32x |
Interest Paid | 1.83M | 2.25M | 2.08M | 1.52M | 1.78M | 2.78M | 3.12M | 0 | 475K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.84M |
GRDN Key Ratios
Guardian Pharmacy Services, Inc. (GRDN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 45.43% | 42.08% | 27.1% | 54.81% | 35.2% | -83.2% | 26.76% | 25.71% |
Return on Invested Capital (ROIC) | 26.36% | 23.57% | 21.25% | 33.66% | 23.04% | -30.36% | 35.84% | 35.64% |
Gross Margin | 20.54% | 19.97% | 20.36% | 20.45% | 19.91% | 19.89% | 19.47% | 20.19% |
Net Margin | 3.11% | 2.71% | 2.06% | 3.9% | 2.28% | -7.11% | 3.4% | 3.64% |
Debt / Equity | 2.06x | 0.88x | 1.03x | 0.83x | 1.16x | 0.25x | 0.17x | 0.16x |
Interest Coverage | 14.94x | 14.76x | 18.30x | 26.78x | 14.19x | -19.28x | 133.71x | 129.16x |
FCF Conversion | 2.58x | 2.64x | 3.59x | 1.37x | 2.96x | -0.66x | 2.04x | 1.32x |
Revenue Growth | 16.31% | 5.39% | 7.62% | 14.75% | 15.1% | 17.42% | 17.93% | 13.54% |
Related:GRDN Dividend History·GRDN Revenue History·GRDN Price History·GRDN P/E History·GRDN Financial Ratios·GRDN Institutional Holders
GRDN SEC Filings & Documents
Guardian Pharmacy Services, Inc. (GRDN) SEC filings — annual & quarterly reports (10-K, 10-Q)
GRDN Frequently Asked Questions
Guardian Pharmacy Services, Inc. (GRDN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Guardian Pharmacy Services, Inc. (GRDN) reported $1.46B in revenue for fiscal year 2025. This represents a 143% increase from $600.4M in 2018.
Guardian Pharmacy Services, Inc. (GRDN) grew revenue by 17.9% over the past year. This is strong growth.
Yes, Guardian Pharmacy Services, Inc. (GRDN) is profitable, generating $53.1M in net income for fiscal year 2025 (3.4% net margin).
Dividend & Returns
Guardian Pharmacy Services, Inc. (GRDN) has a return on equity (ROE) of 26.8%. This is excellent, indicating efficient use of shareholder capital.
Guardian Pharmacy Services, Inc. (GRDN) generated $70.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.